Search results

Development of new techniques makes it possible to date Australian Aboriginal rock art.

ANSTOs capabilities are ideally suited for these investigations relating to quantum technologies.

Ultra small angle neutron scattering on Kookaburra is used to study the size and shape of objects of size 10 micrometres and below.

A research paper that shares early results from an IAEA funded project evaluates the state of medical physics in diagnostic radiology and image-guided procedures in the Asia-Pacific region has been published in Physical and Engineering Sciences in Medicine.

ANSTO facilitating coordinated effort to find the nexus that leads to chronic kidney disease of unknown origin

The Australian Synchrotron is a source of powerful X-rays and infrared radiation that can be used for a wide range of scientific and technical purposes. Synchrotron X-rays are millions of times brighter than those produced by conventional X-ray machines in laboratories and hospitals.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.

Dr Helen Maynard-Casely will be taking neutron physics on a road trip

Historic memorandums of understanding on the peaceful use of nuclear with Thailand and Canada.

Spatz neutron reflectometer becomes 15th neutron scattering instrument that is used for studies of biological materials and other soft matter.

Senior electronics engineer from SESAME visits following donation of instrumentation to the Middle East's synchrotron in Jordan.

Research infrastructure will support research and development of advanced concrete.

Twenty-four participants from Asia and the Pacific travelled to ANSTO for an International Atomic Energy Agency Regional Training Course on ‘Production and preclinical evaluation of emerging cyclotron-based radiopharmaceuticals’